Alpha 1-antichymotrypsin (ACT) is an acute-phase plasma glycoprotein encoded by the SERPINA3 gene, primarily produced in the liver. As a member of the serpin superfamily, ACT functions by inhibiting chymotrypsin-like serine proteases, including neutrophil cathepsin G and mast cell chymase. This protective mechanism prevents tissue damage from proteolytic enzymes, particularly in the lower respiratory tract.
ACT is significantly involved in Alzheimer's disease pathology, where it's overexpressed in astrocytes surrounding amyloid plaques, enhancing amyloid-beta fibrillization and inducing tau hyperphosphorylation. It's also elevated in rheumatoid arthritis, Crohn's disease, ulcerative colitis, and following burn injuries.
Clinically, the PSA-ACT complex serves as a valuable biomarker for prostate cancer, indicating tumor mass and clinical staging.
Common uses include Proteolytic enzyme studies, IVD standards, calibrator, and control.
Not a hazardous substance or mixture.
11 - Combustible Solids